Your browser doesn't support javascript.
loading
Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.
Bender, L; Pflumio, C; Trensz, P; Pierard, L; Kalish, M; Fischbach, C; Petit, T.
Afiliação
  • Bender L; Oncology Department, Institut de Cancérologie Strasbourg-Europe, 17 avenue Albert Calmette 672000 Strasbourg, France. Electronic address: l.bender@icans.eu.
  • Pflumio C; Oncology Department, Institut de Cancérologie Strasbourg-Europe, 17 avenue Albert Calmette 672000 Strasbourg, France.
  • Trensz P; Oncology Department, Institut de Cancérologie Strasbourg-Europe, 17 avenue Albert Calmette 672000 Strasbourg, France.
  • Pierard L; Oncology Department, Institut de Cancérologie Strasbourg-Europe, 17 avenue Albert Calmette 672000 Strasbourg, France.
  • Kalish M; Oncology Department, Institut de Cancérologie Strasbourg-Europe, 17 avenue Albert Calmette 672000 Strasbourg, France.
  • Fischbach C; Oncology Department, Institut de Cancérologie Strasbourg-Europe, 17 avenue Albert Calmette 672000 Strasbourg, France.
  • Petit T; Oncology Department, Institut de Cancérologie Strasbourg-Europe, 17 avenue Albert Calmette 672000 Strasbourg, France.
Cancer Treat Res Commun ; 36: 100738, 2023.
Article em En | MEDLINE | ID: mdl-37390791
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2023 Tipo de documento: Article